Motley Fool Australia

Immuron Ltd (ASX: IMC) Share Price and News

Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)

() Chart and Price Data

.

Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range -
Days Range -
Turnover

Fundamental Company Figures

Data provided by Morningstar.
Market Cap $43.18 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 224.10 million
Earnings per share -0.034
Dividend per share N/A
Year To Date Return -17.39%
Earnings Yield N/A
Franking N/A

Immuron Limited (ASX: IMC) Latest News

woman in lab coat conducting testing representing mesoblast share price

Why the Immuron (ASX:IMC) share price fell today

More »

A happy businessman pointing up, inidicating a rise in share price

Why the Immuron (ASX:IMC) share price is rocketing up 10% today

More »

rising asx share price represented by boy dressed in business suit with rocket wings

Why the Immuron (ASX:IMC) share price is rocketing 18% higher today

More »

Buy stocks

Afterpay and Immuron were among the most traded shares on the ASX last week

More »

Orocobre share price recovery from downgradeasx share price rollercoaster represented by rollercoaster on share chart

Immuron share price falls 27% on registered direct offering

More »

Chalk-drawn rocket shown blasting off into space

Immuron share price shoots 90% higher on potential COVID-19 treatment news

More »

Immuron share price shoots 6% higher after receiving FDA guidance for new drug

More »

Recent Stock Announcements

Price Sensitive Only$An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Show All
Date Heading $An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. Time Pages File Size
 

About Immuron Ltd (ASX: IMC)

Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's lead product candidate, IMM-124E, is a proprietary immunomodulator agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

Share Price History

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
16 Apr 2021 $0.19 $0.00 0.00% 174,771 $0.19 $0.19 $0.19
15 Apr 2021 $0.19 $0.00 0.00% 183,823 $0.19 $0.20 $0.19
14 Apr 2021 $0.19 $-0.01 -5.00% 221,692 $0.19 $0.20 $0.19
13 Apr 2021 $0.20 $0.00 0.00% 378,073 $0.19 $0.20 $0.19
12 Apr 2021 $0.20 $0.00 0.00% 230,597 $0.20 $0.20 $0.20
09 Apr 2021 $0.20 $0.01 5.13% 130,587 $0.20 $0.20 $0.20
08 Apr 2021 $0.20 $-0.01 -5.00% 98,813 $0.20 $0.20 $0.20
07 Apr 2021 $0.20 $0.00 0.00% 490,864 $0.21 $0.21 $0.20
06 Apr 2021 $0.21 $0.00 0.00% 139,323 $0.21 $0.21 $0.21
01 Apr 2021 $0.21 $0.00 0.00% 67,200 $0.20 $0.21 $0.20
31 Mar 2021 $0.20 $0.00 0.00% 37,339 $0.20 $0.21 $0.20
30 Mar 2021 $0.20 $0.00 0.00% 121,077 $0.20 $0.20 $0.20
29 Mar 2021 $0.20 $0.00 0.00% 174,488 $0.20 $0.21 $0.20
26 Mar 2021 $0.20 $0.00 0.00% 153,723 $0.20 $0.21 $0.20
25 Mar 2021 $0.20 $0.00 0.00% 419,796 $0.21 $0.21 $0.20
24 Mar 2021 $0.21 $0.00 0.00% 330,466 $0.21 $0.22 $0.21
23 Mar 2021 $0.21 $0.00 0.00% 17,317 $0.21 $0.21 $0.21
22 Mar 2021 $0.21 $0.00 0.00% 4,007 $0.21 $0.21 $0.21
19 Mar 2021 $0.21 $-0.01 -4.76% 214,780 $0.21 $0.21 $0.21
18 Mar 2021 $0.21 $-0.01 -4.65% 99,428 $0.21 $0.22 $0.21
17 Mar 2021 $0.22 $0.00 0.00% 595 $0.22 $0.22 $0.22
Show more

Director Transactions

Data provided by Morningstar.
Date Director Type Amount Value Notes
09 Feb 2021 Ravi Savarirayan Exercise 900 $207,000
09 Feb 2021 Ravi Savarirayan Buy 409 $94,090
20 Nov 2020 Daniel Pollock Sell 100 $26,000
13 Nov 2020 Peter Anastasiou Issued 1 $459,000
13 Nov 2020 Stephen Anastasiou Issued 468 $37,500
13 Nov 2020 Ravi Savarirayan Issued 468 $37,500
13 Nov 2020 Peter Anastasiou Issued 468 $37,500
13 Nov 2020 Ravi Savarirayan Issued 1 $459,000
13 Nov 2020 Stephen Anastasiou Issued 1 $459,000
13 Nov 2020 Roger Aston Issued 1 $459,000
13 Nov 2020 Roger Aston Issued 712 $57,000
13 Nov 2020 Daniel Pollock Buy 29 $7,517
13 Nov 2020 Daniel Pollock Issued 1 $459,000
13 Nov 2020 Daniel Pollock Issued 618 $49,500
13 Nov 2020 Daniel Pollock Sell 100 $27,000
13 Nov 2020 Daniel Pollock Sell 29 $7,517
26 Jun 2020 Stephen Anastasiou Sell 1 $150,674
26 Jun 2020 Peter Anastasiou Sell 964 $79,104
23 Jun 2020 Roger Aston Buy 56 $17,028
23 Jun 2020 Roger Aston Exercise 144 $43,200
23 Jun 2020 Roger Aston Expiry 3 $941,685
23 Jun 2020 Daniel Pollock Buy 29 $8,844
23 Jun 2020 Daniel Pollock Sell 100 $32,500
23 Jun 2020 Daniel Pollock Exercise 74 $22,440
17 Jun 2020 Peter Anastasiou Sell 4 $1,306,326
17 Jun 2020 Peter Anastasiou Sell 1 $429,240
11 Jun 2020 Daniel Pollock Sell 100 $40,480
Show more


Directors & Management

Data provided by Morningstar.
Name Title StartDate Profile
Dr Roger Aston Non-Executive Chairman,Non-Executive Director May 2012
Mr Daniel Pollock Non-Executive Director Oct 2012
Mr Stephen Anastasiou Non-Executive Director May 2013
Mr Peter Anastasiou Executive Director,Vice Chairman May 2015
Mr Ravi Savarirayan Non-Executive Director Apr 2017
Mr Phillip Hains Chief Financial Officer,Company Secretary Apr 2013
Dr Jerry Kanellos Chief Executive Officer Mar 2020
Jerry Kanellos Chief Executive Officer
Phillip Hains Chief Financial Officer,Company Secretary
Show more

Top Share Holders

Data provided by Morningstar.
Name Shares Capital
HSBC Custody Nominees (Australia) Limited 104,631,009 46.57%
Grandlodge Pty Ltd And Its Related Holdings 11,778,269 5.26%
Authentics Australia Pty Ltd <Authentics Australia A/C> 7,500,000 3.35%
Dr Russell Kay Hancock 3,000,000 1.34%
Mr Stephen Anastasiou & Mrs Andria Anastasiou <Anastasiou Family S/F A/C> 2,494,746 1.11%
Insync Investments Pty Ltd <Weekley Super Fund No 1 A/C> 2,000,000 0.89%
Citicorp Nominees Pty Limited 1,719,277 0.77%
Mr Anthony Frederick Wallace Hyett 1,350,000 0.60%
Anne Pattison Pty Ltd <Aep No 3 A/C> 1,345,000 0.60%
Mr William David Frank Bird 1,300,000 0.58%
Inverarey Pty Ltd <The Kilchurn A/C> 1,050,000 0.47%
Texas Woods Pty Ltd <The Plush Family A/C> 978,393 0.44%
Mr Nick Karopoulos 950,000 0.42%
Hadasit Medical Research Services & Development Ltd 887,462 0.40%
Peppertree Custodian Services Pty Ltd <Mulcahy Superannuation A/C> 860,634 0.38%
South Bay Nominees Pty Ltd <C & P Hong Family A/C> 850,000 0.38%
Mr David Anthony Plush & Mrs Ann Louise Plush <Plush Super Fund A/C> 834,075 0.37%
Mrs Rochelle Jane Pattison & Ms Katherine Margaret Forrest <Sylvan S/F A/C> 800,000 0.36%
Advance Publicity Pty Ltd <The Izmar Family A/C> 750,000 0.33%
Show more